These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1106848)

  • 1. Dibromodulcitol (NSC-104800) compared with cyclophosphamide (NSC-26271) as remission maintenance therapy in previously treated children with acute lymphoblastic leukemia or acute undifferentiated leukemia: possible effectiveness in reducing the incidence of central nervous system leukemia.
    Sitarz AL; Albo V; Movassaghi N; Karon M; Hammond D; Weiner J; Reed A
    Cancer Chemother Rep; 1975; 59(5):989-94. PubMed ID: 1106848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclophosphamide (NSC-26271) maintenance therapy after a second remission of childhood acute lymphoblastic leukemia: comparative clinical trial (standard dose versus intermittent high dose versus cyclophosphamide plus cytosine arabinoside (NSC-63878)).
    Albo V; Movassaghi N; Sitarz AL; Hammond D; Weiner J; Reed A
    Cancer Chemother Rep; 1975; 59(6):1097-102. PubMed ID: 769949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission induction in childhood leukemia with second course vincristine (NSC-67574) and prednisone (NSC-10023) therapy.
    Cancer Chemother Rep; 1970 Apr; 54(2):113-8. PubMed ID: 4946001
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of adult acute lymphoblastic leukemia with cytosine arabinoside, vincristine, and prednisone.
    Gingrich RD; Armitage JO; Burns CP
    Cancer Treat Rep; 1978 Sep; 62(9):1389-91. PubMed ID: 356988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the use of "prophylactic" intrathecal amethopterin in childhood leukemia.
    Melhorn DK; Gross S; Fisher BJ; Newman AJ
    Blood; 1970 Jul; 36(1):55-60. PubMed ID: 5268195
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide-asparaginase- vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia.
    Komp DM; George SL; Falletta J; Land VJ; Starling KA; Humphrey GB; Lowman J
    Cancer; 1976 Mar; 37(3):1243-7. PubMed ID: 1063049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daunorubicin (NSC-83142) versus daunorubicin plus prednisone (NSC-10023) versus daunorubicin plus vincristine (NSC-67574) plus prednisone in advanced childhood acute lymphocytic leukemia.
    Jones B; Cuttner J; Levy RN; Patterson RB; Kung F; Pleuss HJ; Falkson G; Treat CL; Haurani F; Burgert EO; Rosner F; Carey RW; Lukens J; Blom J; Degnan TJ; Wohl H; Glidewell O; Holland JF
    Cancer Chemother Rep; 1972 Dec; 56(6):729-37. PubMed ID: 4574054
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylactic central nervous system therapy in childhood acute lymphatic leukemia. Effect of poor-risk patients on the results.
    Virag I; Kende G; Agahai E; Ramot B
    Isr J Med Sci; 1976 Nov; 12(11):1269-74. PubMed ID: 797678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
    Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
    Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute lymphoblastic leukemia of childhood: results of combination therapy.
    Hutter JJ; Hays T; Holton CP; Mayer CM; Baum ES; Chapman KE; Phillips LK; Haerr M
    Rocky Mt Med J; 1974 Nov; 71(11):645-9. PubMed ID: 4372664
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
    Wiernik PH; Schimpff SC; Schiffer CA; Lichtenfeld JL; Aisner J; O'Connell MJ; Fortner C
    Cancer Treat Rep; 1976 Jan; 60(1):41-53. PubMed ID: 1069608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
    Bodey GP; Rodriguez V; Hart J; Freireich EJ
    Cancer Chemother Rep; 1970 Aug; 54(4):255-62. PubMed ID: 4946010
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of acute lymphoblastic leukemia].
    Paolucci G; Rosito P
    Minerva Pediatr; 1971 Nov; 23(44):1851-69. PubMed ID: 4950250
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
    Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
    Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of cytosine arabinoside (NSC-63878) and prednisone (NSC-10023) in refractory childhood lymphoblastic leukemia.
    Nesbit ME; Sonley M; Hammond D
    Med Pediatr Oncol; 1976; 2(1):61-8. PubMed ID: 1064743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
    Curtis JE; Cowan DH; Bergsagel DE; Hasselback R; McCulloch EA
    Can Med Assoc J; 1975 Aug; 113(4):289-94. PubMed ID: 1056807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of cytosine arabinoside (NSC-63878) synchronization plus vincristine (NSC-67574), prednisone (NSC-10023), and L-asparaginase (NSC-109229) for remission induction in advanced acute leukemia in children.
    Sutow WW; Thomas D; Steuber CP; Pullen J; Vats T; Bryan JH; Morgan SK
    Cancer Treat Rep; 1976 May; 60(5):591-4. PubMed ID: 991148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of vincristine utilized simultaneously or 24 hours before cyclophosphamide in maintenance regimen of acute lymphoblastic leukemia of children: a report of Childrens Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1981; 3(3):227-31. PubMed ID: 6945059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cyclophosphamide (NSC-26271) therapy in childhood acute leukemia.
    Steuber CP; Fernbach DJ; Starling KA; Falletta JM
    Cancer Chemother Rep; 1974; 58(3):417-9. PubMed ID: 4601672
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of acute lymphoblastic leukemia.
    Burchenal JH; Dowling MD; Tan CT
    Annu Rev Med; 1972; 23():77-92. PubMed ID: 4118886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.